Development of an in vivo rat screen model to predict pharmacokinetic interactions of CYP3A4 substrates

Author： Mandlekar S. V. Rose A. V. Cornelius G. Sleczka B. Caporuscio C. Wang J. Marathe P. H.

ISSN： 1366-5928

Source： Xenobiotica, Vol.37, Iss.9, 2007-09, pp. : 923-942

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A new approach to predicting human hepatic clearance of CYP3A4 substrates using monkey pharmacokinetic data

By Ogawa Kotaro Kato Motohiro Houjo Takao Ishigai Masaki

Xenobiotica, Vol. 43, Iss. 5, 2013-05 ,pp. : 468-478

Informa Healthcare

Access to resources Recommend Favorite

Studies on the induction of rat hepatic CYP1A, CYP2B, CYP3A and CYP4A subfamily form mRNAs in vivo and in vitro using precision-cut rat liver slices

By Meredith C. Scott M. P. Renwick A. B. Price R. J. Lake B. G.

Xenobiotica, Vol. 33, Iss. 5, 2003-01 ,pp. : 511-527

Informa Healthcare

Access to resources Recommend Favorite

Role of CYP3A in bromperidol metabolism in rat in vitro and in vivo

By Watanabe M. Tateishi T. Tanaka M. Kumai T. Kobayashi S.

Xenobiotica, Vol. 29, Iss. 8, 1999-08 ,pp. : 839-846

Informa Healthcare

Access to resources Recommend Favorite

Homology modelling of CYP3A4 from the CYP2C5 crystallographic template: analysis of typical CYP3A4 substrate interactions

By Lewis D. F. V. Lake B. G. Dickins M. Goldfarb P. S.

Xenobiotica, Vol. 34, Iss. 6, 2004-06 ,pp. : 549-569

Informa Healthcare

Access to resources Recommend Favorite

Comparative analysis of substrate and inhibitor interactions with CYP3A4 and CYP3A5

By Soars M. G. Grime K. Riley R. J.

Xenobiotica, Vol. 36, Iss. 4, 2006-04 ,pp. : 287-299

Informa Healthcare

Access to resources Recommend Favorite